


Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease
Rituximab Seems Safe & Effective for Systemic Sclerosis

Insights Into Ulnar Artery Occlusion in Systemic Sclerosis

FDA Approves Tocilizumab to Treat Systemic Sclerosis-Associated ILD
Barrett’s Esophagus Common in Women with Scleroderma

Study: DPP4 Inhibitors Yield Promise for Systemic Sclerosis Treatment
Lenabasum for Diffuse Cutaneous Systemic Sclerosis

Systemic Sclerosis Patients May Benefit from Targeted Stroke Screening
